Market size Exactech operates in the orthopaedic implant and biologics space with revenue in the mid-range ($100M-$250M) and a global market footprint across the US and 30+ markets. Potential sales opportunity: target hospitals and distributors in regions with growing orthopedic procedures and replace/upgrade implants, instrumentation, and biologics portfolios.

Expansion potential With a Gainesville manufacturing base and international distribution, there may be capacity to scale through expanded instrument sets, spine, knee, and hip solutions, as well as biologics. Sales focus: present bundled modernization programs and service agreements to increase adoption in existing and new markets.

Tech alignment Exactech’s stack includes ISO 13485 compliance and GDPR readiness, plus ERP/instrumentation tech like NetApp and Microsoft Intune. Opportunity: propose integrated quality, data analytics, and supply-chain optimization solutions that align with their regulatory and data governance needs.

Regulatory posture Emphasis on regulatory compliance (ISO 13485) and global market presence suggests a readiness for solutions that streamline regulatory filings, post-market surveillance, and product lifecycle management. Sales angle: offer compliance automation, documentation management, and audit-ready workflows.

Customer reach Longstanding distributor network in 30+ markets and direct hospital partnerships indicate potential for value-added services such as training, onboarding programs, and instrument kits optimization. Target hospitals and surgeons with workflow efficiency tools and enhanced patient outcomes through improved implant systems.